Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2

Status

Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1

Conditions

Multiple Myeloma 2Back Pain 2Osteoporosis 1Neoplasms 1Bone Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Kyphoplasty × Clear all
NCT00211211 2017-12-08

FREE Study - Fracture Reduction Evaluation

Medtronic Spinal and Biologics

Phase 4 Completed
300 enrolled
Plasma cellSarcoma

Back Pain, Bone Diseases, Metabolic, Bone Neoplasms, Multiple Myeloma, Osteoporosis

NCT01410929 2017-01-20

MM

Merit Medical Systems, Inc.

Phase 4 Withdrawn
Plasma cell

Back Pain, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡